 CAMBRIDGE, Mass., Sept. 06, 2022 GLOBE NEWSWIRE -- Tango Therapeutics, Inc. NASDAQ: TNGX, a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in the H.C. Wainwright 24th Annual Global Investment Conference. The presentation will be available on-demand starting on Monday, September 12, 2022 at 7:00 AM ET. 